Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Multi-national Investigator-Initiated Clinical Studies in Cardiovascular, Autoimmune, Metabolic, and Non-Communicable Respiratory Diseases, including Underrepresented Populations – IICS4all 2027

    IICS4all 2027 supports multinational research teams conducting randomized trials of existing interventions or repurposed medicines to improve clinical practice and healthcare in four disease areas.

    Browse similar grants
    Public Health Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Funder: Austrian Science Fund (FWF)

    Due Dates: November 30, 2026 (ECRIN contact) | January 14, 2027 (Joint pre-proposal) | January 15, 2027 (FWF pre-proposal) | June 14, 2027 (Joint full proposal) | June 15, 2027 (FWF full proposal)

    Funding Amounts: €200,000–€450,000 per FWF-funded project for 24–48 months

    Summary: Supports multinational, investigator-initiated randomized clinical trials comparing existing interventions or repurposing off-patent drugs in four major disease areas.

    Key Information: Austrian applicants must submit at both stages to the Call Secretariat and FWF, with institutional approval.


    Description

    IICS4all 2027 is the ninth joint transnational call of ERA4Health, supported in Austria by FWF and co-financed by the European Union. It funds pragmatic, phase III, randomized controlled, multinational interventional investigator-initiated clinical studies with high public relevance. Eligible work comprises comparative-effectiveness studies and/or repurposing studies of approved, off-patent medicines in cardiovascular diseases, metabolic disorders, autoimmune diseases and non-communicable respiratory diseases. These areas have equal priority, and related comorbidities may be included.

    The call seeks evidence that improves clinical practice, use of existing health technologies, population health and healthcare delivery. Studies must ensure inclusive, representative populations and address relevant sex, gender, age and other diversity-related aspects. Existing cohorts may support randomized designs, including Trials within Cohorts.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.